Hyperthermia |
Increased heat production |
Muscular hyperactivity/rigidity |
Sympathomimetics |
Cocaine |
Amphetamines |
Phenylpropanolamine |
Ephedrine |
Cathinones |
Anticholinergics |
Drug withdrawal states |
Lithium |
Central hallucinogens |
Phencyclidine |
Lysergic acid diethylamide (LSD) |
Designer amphetamines (MDMA, MDEA) |
Synthetic cannabinoids |
Drugs causing recurrent seizures |
Isoniazid |
Theophylline |
Phenethylamines |
Strychnine |
Neuroleptic malignant syndrome |
Serotonin syndrome |
MAO inhibitors |
Malignant hyperthermia |
Impaired heat dissipation |
Impaired sweating |
Anticholinergic agents |
Antihistamines |
Phenothiazines |
Tricyclic antidepressants |
Increased metabolic rate |
Uncoupled oxidative phosphorylation |
Salicylates |
Dinitrophenol, pentachlorophenol |
Thyroid hormone |